Serum Human IgG 4 Test at Chughtai Lab

Serum Human IgG 4 at Chughtai Lab

The Serum Human Immunoglobulin G4 (IgG4) test is a highly specialized immunological assay performed to measure the concentration of the IgG4 subclass in a patient’s blood. Immunoglobulins, or antibodies, are proteins produced by the immune system’s plasma cells to identify and neutralize foreign pathogens such as bacteria and viruses. Human IgG is divided into four distinct subclasses: IgG1, IgG2, IgG3, and IgG4. Among these, IgG4 is the least common, typically accounting for less than five percent of the total circulating IgG pool in healthy individuals. Despite its low concentration, IgG4 plays a critical role in the immune system, particularly in mediating anti-inflammatory responses and tolerance. However, abnormal elevations of this specific subclass are strongly associated with a spectrum of fibro-inflammatory disorders collectively known as IgG4-Related Disease (IgG4-RD).

At Chughtai Lab, Pakistan’s premier diagnostic network, the Serum Human IgG4 test is performed using advanced automated immunoassay platforms, such as nephelometry or enzyme-linked immunosorbent assay (ELISA). These technologies provide high sensitivity and specificity, ensuring precise quantification of IgG4 levels in the blood. The evaluation of Serum IgG4 is clinically vital for distinguishing IgG4-RD from other inflammatory, autoimmune, or malignant conditions that can mimic its presentation. By measuring this biomarker, clinicians can accurately assess systemic involvement, formulate targeted therapeutic strategies, and monitor patient response to immunosuppressive treatments. This test serves as a cornerstone in modern clinical immunology, offering invaluable diagnostic insights that help avoid invasive surgical biopsies when clinical and radiological findings align.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest level of accuracy and prevent any potential interference with the test results, patients are advised to follow these preparation guidelines:

• No Fasting Required: Standard fasting is generally not required for the Serum Human IgG4 test. Patients can eat and drink normally prior to sample collection unless instructed otherwise by their physician for concurrent tests.
• Medication Disclosure: It is crucial to inform the healthcare provider and the laboratory staff about all current medications, especially immunosuppressants, systemic corticosteroids (such as prednisone), or chemotherapy drugs, as these can artificially lower immunoglobulin levels.
• Hydration: Staying well-hydrated by drinking plenty of water before the test is highly recommended, as it makes the veins more accessible for venipuncture.
• Avoid Strenuous Exercise: Patients should avoid vigorous physical activity immediately before the blood draw to maintain baseline physiological conditions.

During the Procedure

The collection of a blood sample for the Serum Human IgG4 test is a standard, safe, and quick procedure conducted by trained phlebotomists at Chughtai Lab:

• Patient Positioning: The patient is comfortably seated, and the phlebotomist inspects the arm to locate a suitable vein, typically in the antecubital fossa (the crook of the elbow).
• Sanitization: The skin over the selected vein is thoroughly cleansed with an antiseptic swab to prevent any bacterial contamination.
• Venipuncture: A sterile, single-use needle is gently inserted into the vein. A small volume of blood is drawn into a specialized collection tube (typically a serum separator tube).
• Sensation: Patients may feel a brief, mild pinch or stinging sensation as the needle enters the skin, which subsides quickly.
• Post-Collection Care: Once the sample is collected, the needle is withdrawn, and a sterile cotton ball or gauze is applied to the puncture site with gentle pressure to stop any bleeding. A small bandage is then placed over the site.
• Duration: The entire venipuncture process takes less than five minutes, and patients can immediately resume their daily activities.

When is a Serum Human IgG 4 Test Performed?

Suspected IgG4-Related Disease (IgG4-RD)

Physicians request the Serum Human IgG4 test when a patient presents with multi-organ swelling or tumor-like masses that suggest IgG4-Related Disease. This systemic condition can affect virtually any organ, leading to tissue dysfunction, fibro-inflammatory infiltration, and eventual scarring. Common symptoms include unexplained weight loss, fatigue, and localized swelling in organs such as the pancreas, kidneys, or lungs. Measuring serum IgG4 levels helps clinicians differentiate this treatable autoimmune condition from malignancies, which often present with similar radiological findings but require entirely different therapeutic approaches.

Autoimmune Pancreatitis (Type 1)

Autoimmune Pancreatitis (AIP) Type 1 is the pancreatic manifestation of IgG4-RD. Patients often present with obstructive jaundice, mild abdominal pain, and a diffuse enlargement of the pancreas, frequently referred to as a sausage-like pancreas on imaging scans. Because these clinical features closely mimic pancreatic ductal adenocarcinoma, the Serum IgG4 test is critical. A significantly elevated IgG4 level strongly supports a diagnosis of AIP Type 1, helping patients avoid unnecessary pancreatic resections and allowing for the prompt initiation of corticosteroid therapy, to which AIP typically responds exceptionally well.

Unexplained Salivary or Lacrimal Gland Swelling

Chronic, bilateral, painless swelling of the salivary (parotid and submandibular) and lacrimal glands is a classic presentation of IgG4-RD, historically referred to as Mikulicz’s disease. Patients may experience dry mouth (xerostomia) and dry eyes (xerophthalmia), which can be confused with Sjögren’s syndrome. A Serum Human IgG4 test is performed to distinguish between these two conditions. Elevated IgG4 levels point toward IgG4-RD, whereas Sjögren’s syndrome is typically characterized by specific autoantibodies like anti-SSA and anti-SSB, with normal IgG4 concentrations.

Retroperitoneal Fibrosis and Renal Dysfunction

Retroperitoneal fibrosis is a rare condition characterized by the development of abnormal fibrous tissue in the retroperitoneal space, which can encase the ureters and abdominal aorta, leading to hydronephrosis and progressive renal failure. Patients may present with dull, poorly localized back or flank pain, lower extremity edema, and elevated serum creatinine. When retroperitoneal fibrosis is suspected to be IgG4-related, the Serum IgG4 test is performed. Identifying an IgG4-related etiology is crucial, as it indicates that the fibrotic process is highly responsive to medical immunosuppression rather than requiring complex surgical decompression.

Monitoring Treatment Response in Inflammatory Conditions

For patients already diagnosed with IgG4-RD, the Serum Human IgG4 test is performed periodically to monitor the efficacy of immunosuppressive therapy, such as systemic corticosteroids or rituximab. A successful response to treatment is typically accompanied by a significant decline in serum IgG4 levels, alongside clinical and radiological improvement. Conversely, a rising trend in IgG4 levels during or after treatment tapering can serve as an early biochemical warning sign of an impending clinical relapse, allowing rheumatologists to adjust medication dosages proactively.

What Does a Serum Human IgG 4 Test Detect?

The Serum Human IgG4 test provides precise diagnostic data regarding the concentration of IgG4 antibodies in the circulation. Specifically, this test detects and assists in evaluating:

• Elevated IgG4 Concentrations: Levels above the reference range (typically greater than 135 mg/dL) are highly suggestive of IgG4-Related Disease.
• Active Autoimmune Pancreatitis (Type 1): Marked elevations help confirm pancreatic involvement and differentiate it from pancreatic cancer.
• Mikulicz’s Disease: Confirms the involvement of salivary and lacrimal glands in the context of systemic IgG4-RD.
• Riedel’s Thyroiditis: Detects potential IgG4-related systemic involvement in patients presenting with a hard, fixed thyroid mass.
• Küttner’s Tumor: Identifies chronic sclerosing sialadenitis, a benign inflammatory condition of the submandibular gland.
• IgG4-Related Nephritis: Assists in identifying the underlying cause of unexplained interstitial nephritis or membranous glomerulonephritis.
• IgG4-Related Ophthalmic Disease: Detects systemic links in patients presenting with orbital pseudotumors or extraocular muscle swelling.
• Retroperitoneal Fibrosis: Helps establish an autoimmune, treatable etiology for retroperitoneal masses.
• IgG4-Related Lymphadenopathy: Evaluates patients with generalized, unexplained lymph node enlargement.
• IgG4-Related Pachymeningitis: Assists in diagnosing hypertrophic cranial or spinal pachymeningitis presenting with headaches or neurological deficits.
• IgG4-Related Lung Disease: Evaluates interstitial lung disease, nodules, or pleural thickening of unknown origin.
• Aortitis and Periaortitis: Identifies inflammatory involvement of the thoracic or abdominal aorta.
• Prostatic Involvement: Detects IgG4-related prostatitis in patients with lower urinary tract symptoms and prostatic enlargement.
• Skin Manifestations: Evaluates erythematous plaques or nodules associated with systemic IgG4-RD.
• Treatment Efficacy: Detects a reduction in IgG4 levels following corticosteroid or rituximab therapy, indicating positive response.
• Disease Relapse: Identifies rising IgG4 levels, signaling a potential flare-up before clinical symptoms worsen.
• IgG4-to-Total-IgG Ratio: An elevated ratio (often >40%) helps confirm the diagnosis even when total IgG is normal.
• Sjögren’s Syndrome Differentiation: Helps rule out Sjögren’s syndrome in patients with dry eyes and mouth.
• Sarcoidosis Differentiation: Aids in distinguishing IgG4-RD from sarcoidosis, which can present with similar multi-organ involvement.
• Multicentric Castleman Disease Differentiation: Assists in the differential diagnosis of systemic lymphadenopathy.
• Eosinophilia Correlation: Often correlates with elevated peripheral blood eosinophil counts, a common feature of IgG4-RD.
• Hypergammaglobulinemia: Detects the specific subclass responsible for unexplained elevations in total serum protein.
• Response to Steroid Trial: Helps predict which patients with inflammatory masses are likely to respond to steroid therapy.
• Subclinical Organ Involvement: Elevated levels in asymptomatic patients may prompt further radiological screening for silent organ damage.
• Normal IgG4 Levels: Helps rule out IgG4-RD, although a normal level does not entirely exclude the diagnosis in biopsy-proven cases.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to providing accurate and timely diagnostic results. Because the Serum Human IgG4 test is a highly specialized immunological assay requiring sophisticated automated technology, the turnaround time is typically within 3 to 5 working days. This timeframe ensures that the sample undergoes rigorous quality control and verification by consultant pathologists.

Patients can access their diagnostic reports conveniently through multiple digital channels provided by Chughtai Lab. Once the report is finalized, an automated SMS notification containing a direct download link is sent to the patient’s registered mobile number. Reports can also be viewed and downloaded via the official Chughtai Lab website portal or the user-friendly Chughtai Lab Mobile App. For patients who prefer physical copies, reports can be collected directly from any of the numerous Chughtai Lab collection centers located nationwide.

Serum Human IgG 4 Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Serum IgG4 Concentration	Typically < 135 mg/dL (may vary slightly by age and assay)	Elevated levels (> 135 mg/dL), often exceeding 200–500 mg/dL in active IgG4-RD
IgG4 / Total IgG Ratio	Less than 5% to 10%	Elevated ratio (> 40%), strongly indicative of IgG4-Related Disease
Pancreatic Parenchyma	Normal size, homogeneous texture, no masses	Diffuse enlargement (sausage-like pancreas), focal masses, delayed enhancement
Salivary & Lacrimal Glands	Normal size, symmetrical, no tenderness or swelling	Bilateral, painless enlargement of parotid, submandibular, or lacrimal glands
Retroperitoneal Space	Clear tissue planes, normal vascular structures	Fibrotic mass encasing the aorta or ureters, causing hydronephrosis
Renal Function (Associated)	Normal Serum Creatinine and Blood Urea Nitrogen (BUN)	Elevated creatinine, proteinuria, or hematuria due to IgG4-related nephritis
Total Serum Immunoglobulins	All subclasses (IgG1, IgG2, IgG3, IgG4) within reference ranges	Polyclonal hypergammaglobulinemia, specifically driven by elevated IgG4
Treatment Response Marker	Stable baseline levels within normal limits	Significant decrease post-therapy (positive response) or rising levels (relapse)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Serum Human IgG 4?

• ISO 15189 Certified Laboratories: Chughtai Lab adheres to international quality management standards, ensuring highly reliable and accurate test results.
• CAP Proficiency Testing: Participation in the College of American Pathologists (CAP) proficiency surveys guarantees global standards of diagnostic excellence.
• Advanced Immunological Platforms: The laboratory utilizes state-of-the-art automated nephelometry and ELISA systems for precise IgG4 quantification.
• Expert Consultant Pathologists: All specialized immunology reports are reviewed and verified by highly experienced clinical pathologists.
• Nationwide Network: With hundreds of collection centers across Pakistan, accessing high-quality diagnostic services is highly convenient.
• Home Sampling Service: Patients can avail themselves of professional, sterile blood collection in the comfort of their homes through Chughtai Lab’s home sampling team.
• Seamless Digital Access: Quick and secure access to reports via the Chughtai Lab App, official website, and SMS notifications.
• Patient-Centric Care: Dedicated support staff and phlebotomists trained to provide a comfortable, stress-free, and professional diagnostic experience.